Luteolin reduces glucose uptake and malignant phenotypes in pancreatic ductal adenocarcinoma cells: an integrated bioinformatics and in vitro study
Biochemical and Biophysical Research Communications · 2026-09 · 831 · 154332
DOI: 10.1016/j.bbrc.2026.154332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Yunyao Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Huzhou Central Hospital, Fifth School of Clinical Medicine, Zhejiang Chinese Medical University, Huzhou, Zhejiang, 313000, China; Huzhou Central Hosp…. Hauptthemen laut MEDLINE: Luteolin, Carcinoma, Pancreatic Ductal, Glucose, Pancreatic Neoplasms. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Huzhou Municipal Science and Technology Bureau, Zhejiang Administration Bureau of Traditional Chinese Medicine.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) exhibits marked metabolic plasticity, but the effects of luteolin on glucose utilisation in PDAC cells remain unclear. We integrated predicted luteolin targets with bulk and single-cell transcriptomic data, weighted gene co-expression network analysis, machine-learning screening, protein-protein interaction analysis, independent-cohort evaluation, and survival analysis. SLC2A1, MET, and LGALS3 were prioritised as PDAC-associated candidates. In GSE71729, the three-gene expression score was strongly associated with a glycolytic programme, and this association remained robust after removal of overlapping genes from the pathway gene sets. In ASPC-1 and PANC-1 cells, luteolin reduced cell viability, colony formation, migration, invasion, and glucose uptake, accompanied by lower GLUT1, p-MET, and LGALS3 protein signals. Molecular docking and molecular dynamics further supported predicted structural compatibility between luteolin and GLUT1. These findings identify reduced GLUT1 abundance and glucose uptake as prominent metabolic features of the PDAC cellular response to luteolin and provide a basis for further investigation of glucose-dependent PDAC states.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Huzhou Central Hospital, Fifth School of Clinical Medicine, Zhejiang Chinese Medical University, Huzhou, Zhejiang, 313000, China; Huzhou Central Hospital, Affiliated Central Hospital of Huzhou Normal University, Huzhou,…
Förderung
- Huzhou Municipal Science and Technology Bureau
- Zhejiang Administration Bureau of Traditional Chinese Medicine
Zitieren
APA
Wei, Y., Huang, X., Mei, Y., & Deng, K. (2026). Luteolin reduces glucose uptake and malignant phenotypes in pancreatic ductal adenocarcinoma cells: an integrated bioinformatics and in vitro study. Biochemical and Biophysical Research Communications, 831, 154332. https://doi.org/10.1016/j.bbrc.2026.154332
Vancouver
Wei Y, Huang X, Mei Y, Deng K. Luteolin reduces glucose uptake and malignant phenotypes in pancreatic ductal adenocarcinoma cells: an integrated bioinformatics and in vitro study. Biochemical and Biophysical Research Communications. 2026;831:154332. doi:10.1016/j.bbrc.2026.154332
BibTeX
@article{Wei2026,
author = {Wei, Yunyao and Huang, Xiaolan and Mei, Ying and Deng, Kai},
title = {Luteolin reduces glucose uptake and malignant phenotypes in pancreatic ductal adenocarcinoma cells: an integrated bioinformatics and in vitro study},
journal = {Biochemical and Biophysical Research Communications},
year = {2026},
volume = {831},
pages = {154332},
doi = {10.1016/j.bbrc.2026.154332}
}
EUVIMED